C-Peptide to Glucose Ratio
ورودیهای بالینی بیمار
حداقل ۰.۰۱ — حداکثر ۵۰ • واحد: ng/mL
حداقل ۱۰ — حداکثر ۱۰۰۰ • واحد: mg/dL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Insulin Secretion Deficit0–2
- Impaired Insulin Secretion2–5
- Preserved Insulin Secretion5–999
The C-Peptide to Glucose Ratio calculates assessing beta cell secretory function in patients with diabetes/pre-diabetes. Key inputs include c peptide. Scores guide titrating insulin infusion protocols, managing fluid-electrolyte resuscitation, and long-term risk reduction. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Assesses beta cell secretory function in patients with diabetes/pre-diabetes. The C-peptide to glucose ratio (CGR) is a simple marker that helps evaluate endogenous insulin secretion capacity and can guide diabetes management decisions.
Clinical Indication
The C-Peptide to Glucose Ratio is indicated for bedside clinical practice to support Assesses beta cell secretory function in patients with diabetes/pre-diabetes. The C-peptide to glucose ratio (CGR) is a simple marker that helps evaluate endogenous insulin secretion capacity and can guide diabetes management decisions.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with diabetes mellitus, diabetic ketoacidosis (DKA), hyperosmolar hyperglycemic state, thyroid storm, or adrenal crisis. Clinical application is indicated across Endocrinology clinics, inpatient metabolic services, and acute diabetes care units.
Limitations & Contraindications
Severe hyperglycemia lowers measured serum sodium; corrected sodium equations must guide intravenous fluid selection.
Clinical Pearls & Action Plan
Serial monitoring of serum electrolytes, potassium kinetics, venous pH, and anion gap is mandatory during acute metabolic crisis management. Guideline pearl: Not recommended for patients with chronic kidney disease as C-peptide clearance is reduced.
C-peptide to glucose ratio = serum C-peptide level (ng/mL) / plasma glucose level (mg/dL) × 100
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| c_peptide | float | Yes | Serum C-peptide level(ng/mL) |
| glucose | float | Yes | Plasma glucose level(mg/dL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–2 | Insulin Secretion Deficit | Severe beta cell dysfunction |
| 2–5 | Impaired Insulin Secretion | Moderate beta cell dysfunction |
| 5–999 | Preserved Insulin Secretion | Adequate beta cell function |
Evidence-Based References (EBM)
- Saisho Y. Postprandial C-Peptide to Glucose Ratio as a Marker of β Cell Function: Implication for the Management of Type 2 Diabetes. Int J Mol Sci. 2016 May 6;17(5):744. doi: 10.3390/ijms17050744.DOI: 10.3390/ijms17050744
- Fritsche A, Heni M, Peter A, Stefan N, Häring HU, Wagner R. Different Effects of Lifestyle Intervention in High- and Low-Insulin Secretors. Diabetes Care. 2023 Feb 1;46(2):290-297. doi: 10.2337/dc22-1523.DOI: 10.2337/dc22-1523
- Iwao T, Sakata N, Takeuchi T, Nishimura K, Ohtake S, Akaiwa Y, Kawamura I, Ito A, Yoshida A. Postprandial Serum C-Peptide to Plasma Glucose Ratio Predicts Future Insulin Therapy in Patients with Type 2 Diabetes: A 10-Year Prospective Cohort Study. J Diabetes Investig. 2021 Jan;12(1):68-75. doi: 10.1111/jdi.13304.DOI: 10.1111/jdi.13304